Mitchell Tang, Harvard University, Boston, Massachusetts.
Ateev Mehrotra, Harvard University.
Health Aff (Millwood). 2022 Sep;41(9):1248-1254. doi: 10.1377/hlthaff.2021.02026.
Growing enthusiasm for remote patient monitoring has been motivated by the hope that it can improve care for patients with poorly controlled chronic illness. In a national commercially insured population in the US, we found that billing for remote patient monitoring increased more than fourfold during the first year of the COVID-19 pandemic. Most of this growth was driven by a small number of primary care providers. Among the patients of these providers with a high volume of remote patient monitoring, we did not observe substantial targeting of remote patient monitoring to people with greater disease burden or worse disease control. Further research is needed to identify which patients benefit from remote patient monitoring, to inform evidence-based use and coverage decisions. In the meantime, payers and policy makers should closely monitor remote patient monitoring use and spending.
远程患者监测日益受到关注,其初衷是希望改善慢性病控制不良患者的护理。我们在美国一个全国性的商业保险人群中发现,远程患者监测的计费在 COVID-19 大流行的第一年增加了四倍多。这种增长主要是由少数初级保健提供者推动的。在这些提供者中远程患者监测量较大的患者中,我们并没有发现远程患者监测有针对疾病负担较重或控制较差的患者的现象。还需要进一步研究以确定哪些患者从远程患者监测中受益,从而为循证使用和覆盖决策提供信息。在此期间,支付方和政策制定者应密切监测远程患者监测的使用和支出。